Cross-reactive antibodies in convalescent SARS patients' sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests

Journal of Infection

Volumn 67, Issue 2, 2013, Pages 130-140

  Chan, Kwok Hung ^a   Chan, Jasper Fuk Woo ^a   Tse, Herman ^a,b   Chen, Honglin ^a,b   Lau, Candy Choi Yi ^a   Cai, Jian Piao ^a   Tsang, Alan Ka Lun ^a   Xiao, Xincai ^c   To, Kelvin Kai Wang ^a,b   Lau, Susanna Kar Pui ^a,b   Woo, Patrick Chiu Yat ^a,b   Zheng, Bo Jiang ^a,b   Wang, Ming ^c   Yuen, Kwok Yung ^a,b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b THE UNIVERSITY OF HONG KONG   (Hong Kong)

^c GUANGZHOU CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

Antibody; Betacoronavirus; Coronavirus; Cross reactive; EMC; HKU1; Neutralization; OC43; SARS; Seroprevalence

Indexed keywords

EPITOPE; NEUTRALIZING ANTIBODY; VIRUS ANTIBODY; VIRUS SPIKE PROTEIN;

ADULT; AGED; ANIMAL HUSBANDRY; ANTIBODY TITER; ARTICLE; BIOINFORMATICS; CHINA; CLINICAL ARTICLE; CONTROLLED STUDY; CORONAVIRUS; CROSS REACTION; DISEASE TRANSMISSION; FEMALE; HUMAN; HUMAN CORONAVIRUS EMC; IMMUNOFLUORESCENCE; INFECTION RISK; MALE; SEROPREVALENCE; SEVERE ACUTE RESPIRATORY SYNDROME; VIRUS VIRULENCE; ZOONOSIS;

ADULT; AGED; ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CHINA; CORONAVIRIDAE; CROSS REACTIONS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; MALE; MIDDLE AGED; NEUTRALIZATION TESTS; SEROEPIDEMIOLOGIC STUDIES; SEVERE ACUTE RESPIRATORY SYNDROME; YOUNG ADULT;

EID: 84879302673     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2013.03.015     Document Type: Article

References (63)

1. Chan J.F., Li K.S., To K.K., Cheng V.C., Chen H., Yuen K.Y. Is the discovery of the novel human betacoronavirus 2c EMC/2012 (HCoV-EMC) the beginning of another SARS-like pandemic?. J Infect 2012, 65:477-489.
2. World Health Organization Global alert and response: novel coronavirus infection - update 2012, WHO, Geneva, [accessed 26.03.13]. http://www.who.int/csr/don/2013_03_26/en/index.html.
3. Pollack M.P., Pringle C., Madoff L.C., Memish Z.A. Latest outbreak news from ProMED-mail: novel coronavirus - Middle East. Int J Infect Dis 2012, (12). pii: S1201-9712, 01310-0.
4. Zaki A.M., van Boheemen S., Bestebroer T.M., Osterhaus A.D., Fouchier R.A. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 2012, 367:1814-1820.
5. Woo P.C., Lau S.K., Li K.S., Tsang A.K., Yuen K.Y. Genetic relatedness of the novel human lineage C betacoronavirus to Tylonycteris bat coronavirus HKU4 and Pipistrellus bat coronavirus HKU5. Emerg Microbe Infect 2012, 1:e35. 10.1038/emi.2012.45.
6. van Boheemen S., de Graaf M., Lauber C., Bestebroer T.M., Raj V.S., Am Zaki, et al. Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans. MBio 2012, 3. pii: e00473-12.
7. Woo P.C., Wang M., Lau S.K., Xu H., Poon R.W., Guo R., et al. Comparative analysis of twelve genomes of three novel group 2c and group 2d coronaviruses reveals unique group and subgroup features. J Virol 2007, 81:1574-1585.
8. Annan A., Baldwin H.J., Corman V.M., Sm Klose, Owusu M., Nkrumah E.E., et al. Human betacoronavirus 2c EMC/2012-related viruses in bats, Ghana and Europe. Emerg Infect Dis 2013, http://wwwnc.cdc.gov/eid/article/19/3/12-1503_article.htm.
9. Reusken C.B., Lina P.H., Pielaat A., de Vries A., Dam-Deisz C., Adema J., et al. Circulation of group 2 coronaviruses in a bat species common to urban areas in Western Europe. Vector Borne Zoonotic Dis 2010, 10:785-791.
10. Bermingham A., Chand M.A., Brown C.S., Aarons E., Tong C., Langrish C., et al. Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East. Euro Surveill September 2012, 2012(17):2020290.
11. Cheng V.C., Lau S.K., Woo P.C., Yuen K.Y. Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection. Clin Microbiol Rev 2007, 20:660-694.
12. Woo P.C., Lau S.K., Tsoi H.W., Chan K.H., Wong B.H., Che X.Y., et al. Relative rates of non-pneumonic SARS coronavirus infection and SARS coronavirus pneumonia. Lancet 2004, 363:841-845.
13. Lau S.K., Woo P.C., Yip C.C., Tse H., Tsoi H.W., Cheng V.C., et al. Coronavirus HKU1 and other coronavirus infections in Hong Kong. J Clin Microbiol 2006, 44:2063-2071.
14. Woo P.C., Lau S.K., Tsoi H.W., Tsoi H.W., Huang Y., Poon R.W., et al. Clinical and molecular epidemiological features of coronavirus HKU1-associated community-acquired pneumonia. J Infect Dis 2005, 192:1898-1907.
15. Fouchier R.A., Hartwig N.G., Bestebroer T.M., Niemeyer B., de Jong J.C., Simon J.H., et al. A previously undescribed coronavirus associated with respiratory disease in humans. Proc Natl Acad Sci U.S.A 2004, 101:6212-6216.
16. van der Hoek L., Pyrc K., Jebbink M.F., Vermeulen-Oost W., Berkhout R.J., Wolthers K.C., et al. Identification of a new human coronavirus. Nat Med 2004, 10:368-373.
17. Tyrrell D.A., Bynoe M.L. Cultivation of viruses from a high proportion of patients with colds. Lancet 1966, 1:76-77.
18. Hamre D., Procknow J.J. A new virus isolated from the human respiratory tract. Proc Soc Exp Biol Med 1966, 121:190-193.
19. Lau S.K., Woo P.C., Li K.S., Huang Y., Tsoi H.W., Wong B.H., et al. Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats. Proc Natl Acad Sci USA 2005, 102:14040-14045.
20. Yuen K.Y., Chan P.K., Peiris M., Tsang D.N., Que T.L., Shortridge K.F., et al. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet 1998, 351:467-471.
21. Beigel J.H., Farrar J., Han A.M., Hayden F.G., Hyer R., de Jong M.D., et al. Avian influenza A (H5N1) infection in humans. N Engl J Med 2005, 353:1374-1385.
22. To K.K., Ng K.H., Que T.L., Chan J.M., Tsang K.Y., Tsang A.K., et al. Avian influenza A H5N1 virus: a continuous threat to humans. Emerg Microbe Infect 2012, 1:e25. 10.1038/emi.2012.24.
23. Chan J.F., Chan K.H., Choi G.K., To K.K., Tse H., Cai J.P., et al. Differential cell line susceptibility to the emerging novel human betacoronavirus 2c EMC/2012: implications on disease pathogenesis and clinical manifestation. J Infect Dis 2013 Apr 11, [Epub ahead of print].
24. Müller M.A., Raj V.S., Muth D., Meyer B., Kallies S., Smits S.L., et al. Human coronavirus emc does not require the SARS-coronavirus receptor and maintains broad replicative capability in mammalian cell lines. MBio 2012, 3. pii:e00515-12.
25. Woo P.C., Lau S.K., Chu C.M., Chan K.H., Tsoi H.W., Huang Y., et al. Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia. J Virol 2005, 79:884-895.
26. Chan C.M., Tse H., Wong S.S., Woo P.C., Lau S.K., Chen L., et al. Examination of seroprevalence of coronavirus HKu1 infection with S protein-based ELISA and neutralization assay against viral spike pseudotyped virus. J Clin Virol 2009, 45:54-60.
27. Zheng B.J., Chan K.W., Lin Y.P., Zhao G.Y., Chan C., Zhang H.J., et al. Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A/H5N1 virus. Proc Natl Acad Sci USA 2008, 105:8091-8096.
28. Chan K.H., Cheng V.C., Woo P.C., Lau S.K., Poon L.L., Guan Y., et al. Serological responses in patients with severe acute respiratory syndrome coronavirus infection and cross-reactivity with human coronaviruses 229E, OC43, and NL63. Clin Diagn Lab Immunol 2005, 12:1317-1321.
29. Woo P.C., Lau S.K., Wong B.H., Tsoi H.W., Fung A.M., Kao R.Y., et al. Differential sensitivities of severe acute respiratory syndrome (SARS) coronavirus spike polypeptide enzyme-linked immunosorbent assay (ELISA) and SARS coronavirus nucleocapsid protein ELISA for serodiagnosis of SARS coronavirus pneumonia. J Clin Microbiol 2005, 43:3054-3058.
30. Woo P.C., Lau S.K., Wong B.H., Chan K.H., Hui W.T., Kwan G.S., et al. False-positive results in a recombinant severe acute respiratory syndrome-associated coronavirus (SARS-CoV) nucleocapsid enzyme-linked immunosorbent assay due to HCoV-OC43 and HCoV-229E rectified by Western blotting with recombinant SARS-CoV spike polypeptide. J Clin Microbiol 2004, 42:5885-5888.
31. Woo P.C., Lau S.K., Wong B.H., Tsoi H.W., Fung A.M., Chan K.H., et al. Detection of specific antibodies to severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein for serodiagnosis of SARS coronavirus pneumonia. J Clin Microbiol 2004, 42:2306-2309.
32. Lau S.K., Woo P.C., Wong B.H., Tsoi H.W., Woo G.K., Poon R.W., et al. Detection of severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in sars patients by enzyme-linked immunosorbent assay. J Clin Microbiol 2004, 42:2884-2889.
33. Pei J., Tang M., Grishin N.V. PROMALS3D web server for accurate multiple protein sequence and structure alignments. Nucleic Acids Res 2008, 36:W30-W34.
34. Rubinstein N.D., Mayrose I., Martz E., Pupko T. Epitopia: a web-server for predicting B-cell epitopes. BMC Bioinform 2009, 10:287.
35. Krogh A., Larsson B., von Heijne G., Sonnhammer E.L. Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J Mol Biol 2001, 305:567-580.
36. Delorenzi M., Speed T. An HMM model for coiled-coil domains and a comparison with PSSM-based predictions. Bioinformatics 2002, 18:617-625.
37. Elshabrawy H.A., Coughlin M.M., Baker S.C., Prabhakar B.S. Human monoclonal antibodies against highly conserved HR1 and HR2 domains of the SARS-CoV spike protein are more broadly neutralizing. PLoS One 2012, 7:e50366.
38. Che X.Y., Qiu L.W., Pan Y.X., Wen K., Hao W., Zhang L.Y., et al. Sensitive and specific monoclonal antibody-based capture enzyme immunoassay for detection of nucleocapsid antigen in sera from patients with severe acute respiratory syndrome. J Clin Microbiol 2004, 42:2629-2635.
39. Blanchard E.G., Miao C., Haupt T.E., Anderson L.J., Haynes L.M. Development of a recombinant truncated nucleocapsid protein based immunoassay for detection of antibodies against human coronavirus OC43. J Virol Methods 2011, 177:100-106.
40. He Y., Li J., Li W., Lustigman S., Farzan M., Jiang S. Cross-neutralization of human and palm civet severe acute respiratory syndrome coronaviruses by antibodies targeting the receptor-binding domain of spike protein. J Immunol 2006, 176:6085-6092.
41. Akerström S., Tan Y.J., Mirazimi A. Amino acids 15-28 in the ectodomain of SARS coronavirus 3a protein induces neutralizing antibodies. FEBS Lett 2006, 580:3799-3803.
42. Buchholz U.J., Bukreyev A., Yang L., Lamirande E.W., Murphy B.R., Subbarao K., et al. Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity. Proc Natl Acad Sci USA 2004, 101:9804-9809.
43. Jiang S., Lu L., Du L., Debnath A.K. A predicted receptor-binding and critical neutralizing domain in S protein of the novel human coronavirus HCoV-EMC. J Infect 2012, (12):384-392. pii: S0163-4453.
44. He Y., Zhu Q., Liu S., Zhou Y., Yang B., Li J., et al. Identification of a critical neutralization determinant of severe acute respiratory syndrome (SARS)-associated coronavirus: importance for designing SARS vaccines. Virology 2005, 339:213-225.
45. Hung I.F., Cheng V.C., Wu A.K., Tang B.S., Chan K.H., Chu C.M., et al. Viral loads in clinical specimens and SARS manifestations. Emerg Infect Dis 2004, 10:1550-1557.
46. Corman V., Müller M., Costabel U., Timm J., Binger T., Meyer B., et al. Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections. Euro Surveill 2012, 17. pii:20334.
47. Zheng B.J., Guan Y., Hez M.L., Sun H., Du L., Zheng Y., et al. Synthetic peptides outside the spike protein heptad repeat regions as potent inhibitors of SARS-associated coronavirus. Antivir Ther 2005, 10:393-403.
48. Cheng Y., Wong R., Soo Y.O., Wong W.S., Lee C.K., Ng M.H., et al. Use of convalescent plasma therapy in SARS patients in Hong Kong. Eur J Clin Microbiol Infect Dis 2005, 24:44-46.
49. Woo P.C., Lau S.K., Lam C.S., Lai K.K., Huang Y., Lee P., et al. Comparative analysis of complete genome sequences of three avian coronaviruses reveals a novel group 3c coronavirus. J Virol 2009, 83:908-917.
50. Woo P.C., Lau S.K., Lam C.S., Lau C.C., Tsang A.K., Lau J.H., et al. Discovery of seven novel mammalian and avian coronaviruses in the genus deltacoronavirus supports bat coronaviruses as the gene source of alphacoronavirus and betacoronavirus and avian coronaviruses as the gene source of gammacoronavirus and deltavoronavirus. J Virol 2012, 86:3995-4008.
51. Lau S.K., Woo P.C., Yip C.C., Fan R.Y., Huang Y., Wang M., et al. Isolation and characterization of a novel betacoronavirus subgroup A coronavirus, rabbit coronavirus HKU14, from domestic rabbits. J Virol 2012, 86:5481-5496.
52. Lau S.K., Poon R.W., Wong B.H., Wang M., Huan Y., Xu H., et al. Coexistence of different genotypes in the same bat and serological characterization of Rousettus bat coronavirus HKU9 belonging to a novel Betacoronavirus subgroup. J Virol 2010, 84:11385-11394.
53. Lau S.K., Woo P.C., Li K.S., Huang Y., Wang M., Lam C.S., et al. Complete genome sequence of bat coronavirus HKU2 from Chinese horseshoe bats revealed a much smaller spike gene with a different evolutionary lineage from the rest of the genome. Virology 2007, 367:428-439.
54. Woo P.C., Lau S.K., Huang Y., Yuen K.Y. Coronavirus diversity, phylogeny and interspecies jumping. Exp Biol Med (Maywood) 2009, 234:1117-1127.
55. Woo P.C., Lau S.K., Yuen K.Y. Infectious diseases emerging from Chinese wet-markets: zoonotic origins of severe respiratory viral infections. Curr Opin Infect Dis 2006, 19:401-407.
56. Lau S.K., Li K.S., Tsang A.K., Shek C.T., Wang M., Choi G.K., et al. Recent transmission of a novel alphacoronavirus, bat coronavirus HKU10, from Leschenault's rousettes to pomona leaf-nosed bats: first evidence of interspecies transmission of coronavirus between bats of different suborders. J Virol 2012, 86:11906-11918.
57. Lau S.K., Lee P., Tsang A.K., Yip C.C., Tse H., Lee R.A., et al. Molecular epidemiology of human coronavirus OC43 reveals evolution of different genotypes over time and recent emergence of a novel genotype due to natural recombination. J Virol 2011, 85:11325-11337.
58. Peiris J.S., Yuen K.Y., Osterhaus A.D., Stöhr K. The severe acute respiratory syndrome. N Engl J Med 2003, 349:2431-2441.
59. Peiris J.S., Lai S.T., Poon L.L., Guan Y., Yam L.Y., Lim W., et al. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 2003, 361:1319-1325.
60. Fouchier R.A., Kuiken T., Schutten M., van Amerongen G., van Doornum G.J., van den Hoogen B.G., et al. Aetiology: Koch'spostulates fulfilled for SARS virus. Nature 2003, 423:240.
61. Ksiazek T.G., Erdman D., Goldsmith C.S., Zaki S.R., Peret T., Emery S., et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 2003, 348:1953-1966.
62. Drosten C., Günther S., Preiser W., van der Werf S., Brodt H.R., Becker S., et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003, 347:1967-1976.
63. Keng C.T., Zhang A., Shen S., Lip K.M., Fielding B.C., Tan T.H., et al. Amino acids 1055 to 1192 in the S2 region of severe acute respiratory syndrome coronavirus S protein induce neutralizing antibodies: implications for the development of vaccines and antiviral agents. J Virol 2005 Mar, 79:3289-9326.